ISIN | LU0426487442 |
---|---|
Numero di valore | 10173746 |
Bloomberg Global ID | BBG000LZWTW4 |
Nome del fondo | PPF ("PMG Partners Funds") - PMG Global Biotech Fund I |
Offerente del fondo |
PMG Investment Solutions AG
Zug, Schweiz Telefono: +41 44 215 28 38 E-Mail: pmg@pmg.swiss Web: https://www.pmg.swiss |
Offerente del fondo | PMG Investment Solutions AG |
Rappresentante in Svizzera |
PMG Investment Solutions AG Zug Telefono: +41 44 215 28 38 |
Distributore(i) |
PMG Investment Solutions AG Zug Telefono: +41 44 215 28 38 |
Asset class | Fondi azionari |
EFC Categoria | |
Classe di quote | Accumulation |
Paese di domicilio | Lussemburgo |
Condizioni all-unknown-emissione | Commissione di emissione a favore della direzione del fondo e/o del distributore (può variare per stesso fondo a seconda del canale di distribuzione) |
Condizioni al riscatto | Nessuna commissione di riscatto e/o altre commissioni a favore del fondo (riscatto al valore d’inventario) |
Strategia d'investimenti *** | The objective of the investment policy of the Subfund is to achieve the highest possible long-term capital growth in US dollars by taking advantage of the opportunities offered by biotech and pharmaceutical shares on the global stock markets. This involves investing in listed shares of companies that specialise in the identification, development and production of innovative chemical products for the healthcare sector. To achieve the investment objectives, the subfund will primarily invest in equities and, in part, in futures and exchange-traded options. The country-specific focus of the Fund is on the United States, Europe and the Asia region. This focus also includes investments in emerging markets in Europe and Asia. Investments are made in securities irrespective of their market capitalisation (small cap, mid cap, large cap). Up to 10% of the assets of the subfund may also be invested in China Connect Securities via the Stock Connect Programme. |
Particolarità |
Prezzo attuale * | 88.09 USD | 14.11.2024 |
---|---|---|
Prezzo precedente * | 90.18 USD | 13.11.2024 |
Max 52 settimani * | 95.45 USD | 21.08.2024 |
Min 52 settimani * | 76.96 USD | 16.11.2023 |
NAV * | 88.09 USD | 14.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Prezzo minimo indicativo | ||
Attivo del fondo *** | 17'164'238 | |
Attivo della classe *** | 12'350'811 | |
Trading Information SIX |
Performance YTD | +0.66% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
Performance YTD (in CHF) | +6.49% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
1 mese | -3.28% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 mesi | -3.47% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 mesi | +3.26% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 anno | +13.39% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 anni | -9.17% |
14.11.2022 - 14.11.2024
14.11.2022 14.11.2024 |
3 anni | -31.20% |
15.11.2021 - 14.11.2024
15.11.2021 14.11.2024 |
5 anni | -11.87% |
14.11.2019 - 14.11.2024
14.11.2019 14.11.2024 |
Quota di partecipazione al capitale in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Utile totale del fondo in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota immobiliare in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SIGA Technologies Inc | 6.71% | |
---|---|---|
Regeneron Pharmaceuticals Inc | 5.23% | |
Amgen Inc | 5.06% | |
Moderna Inc | 4.84% | |
Vertex Pharmaceuticals Inc | 3.65% | |
Biogen Inc | 3.60% | |
Illumina Inc | 3.60% | |
Chimerix Inc | 3.51% | |
BioNTech SE ADR | 3.31% | |
Seagen Inc Ordinary Shares | 2.86% | |
Ultimo aggiornamento dei dati | 31.08.2022 |
TER | 2.12% |
---|---|
Data TER | 30.06.2024 |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 1.20% |
Ongoing Charges *** | 1.70% |
SRRI ***
|
|
Data SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |